Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada and France. The company develops programs in three areas, including diabetes, anti-inflammatories, and anti-infectives for therapeutics; anti-aging and depigmenting agents in cosmeceuticals; and biological ingredients, such as inducers and adjuvants for the biological development and preservation. It develops a sodium glucose co-transporter inhibitor for the treatment of diabetes, as well as cosmetic skin lightening agents and compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Phone604-641-4466
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$1.15 million
Profitability
Miscellaneous
EmployeesN/A
OptionableNot Optionable
Sirona Biochem (CVE:SBM) Frequently Asked Questions
What is Sirona Biochem's stock symbol?
Sirona Biochem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SBM."
Has Sirona Biochem been receiving favorable news coverage?
Media stories about SBM stock have trended somewhat positive recently, according to InfoTrie. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sirona Biochem earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the immediate future.
Who are some of Sirona Biochem's key competitors?
Some companies that are related to Sirona Biochem include Acasti Pharma (ACST), Bionomics (BNO), IntelGenx Technologies (IGX), CEL-SCI (CVM), Orgenesis (ORGS), Botanix Pharmaceuticals (BOT), Promis Neurosciences (PMN), Protalix Biotherapeutics (PLX), Pediapharm (PDP), Ampio Pharmaceuticals (AMPE), Helix Biopharma (HBP), Actinium Pharmaceuticals (ATNM), Imugene (IMU), Antibe Therapeutics (ATE) and Actinogen Medical (ACW).
Who are Sirona Biochem's key executives?
Sirona Biochem's management team includes the folowing people:
- Dr. Howard J. Verrico M.D., Founder, Chairman, CEO & Sec. (Age 58)
- Mr. Christopher D. Hopton C.G.A., CFO & Director (Age 53)
- Dr. Géraldine Deliencourt-Godefroy Ph.D., Chief Scientific Officer & Director
- Ms. Michelle Seltenrich MBA, VP of Operations
- Ms. Aleksandra Kasikovic, Mang., Bus. Devel.
How do I buy shares of Sirona Biochem?
Shares of SBM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Sirona Biochem's stock price today?
One share of SBM stock can currently be purchased for approximately C$0.13.
How big of a company is Sirona Biochem?
Sirona Biochem has a market capitalization of C$23.38 million and generates C$1.15 million in revenue each year.
What is Sirona Biochem's official website?
How can I contact Sirona Biochem?
The company can be reached via phone at 604-641-4466.
MarketBeat Community Rating for Sirona Biochem (CVE SBM)
MarketBeat's community ratings are surveys of what our community members think about Sirona Biochem and other stocks. Vote "Outperform" if you believe SBM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBM will underperform the S&P 500 over the long term. You may vote once every thirty days.
